Emblem Corp. (TSX-V:EMC) (TSX-V:EMC.WT) (“Emblem” or the “Corporation”) is pleased to announce the appointment of e.vestor Communications Inc. (“EVC”) as the Corporation’s capital markets and investor relations advisor through EVC’s principal, Cory Pala.
Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (“Emblem” or the “Corporation”) is pleased to announce the appointment of e.vestor Communications Inc. (“EVC”) as the Corporation’s capital markets and investor relations advisor through EVC’s principal, Cory Pala. The appointment of EVC remains subject to the approval of the TSX Venture Exchange (the “Exchange).
EVC’s mandate will focus on providing capital markets guidance and support for Emblem through coordinated efforts to navigate the capital markets and support the Corporation’s continued listing on the Exchange. EVC will provide the Corporation with additional capital markets access, investor relations advisory services and broaden awareness of Emblem generally among the investment community (collectively, the “Services”).
The agreement setting out the Services is for an initial term of one (1) year commencing May 7, 2018 to be renewed automatically for successive one (1) year terms. As consideration for the Services, the Corporation shall pay EVC a monthly fee of $10,000 to be paid out monthly.
In connection with the appointment, Emblem shall grant EVC 150,000 options to purchase common shares of the Corporation (the “Options”) with such Options vesting in equal installments over a three (3) year period.
Emblem has no prior professional relationship with EVC. As of the date of this release, EVC does not own or control any securities of the Corporation.
Emblem Corp. is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the ACMPR (Access to Cannabis for Medical Purposes Regulations). Led by a team of cannabis experts and former health care and pharma executives, it has three distinct verticals – cannabis production, patient education centers, and pharmaceutical dosage form development. Emblem trades under the ticker symbol “EMC” on TSX Venture Exchange.
For further information contact:
Chief Financial Officer
This news release may contain “forward-looking information” and “forward-looking statements” within the meaning of applicable Canadian securities legislation, including, without limitation, the future results of operations, performance and achievements of the Corporation. All information contained herein that is not clearly historical in nature may constitute forward-looking information. Except as required by law, the Corporation disclaims any obligation to update or revise any forward-looking statements. Readers are cautioned not to put undue reliance on these forward-looking statements. This news release contains information obtained by the Corporation from third parties and believes such information to be accurate but has not independently verified such information.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.